Peter P. van Rijk - Concepedia

Author

Peter P. van Rijk

Also Known As

B. A. Zonnenberg, P P Van Rijk, P P van Rijk, P. P. VAN RIJK, P. P. Van Rijk, P. P. van RIJK, P. P. van Rijk, P.P van Rijk, P.P. Van Rijk, P.P. van Rijk

128

Publications

3.6K

Citations

H-Index

106

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Heidelberg University University Hospital Heidelberg

About

Peter P. van Rijk is an author at University Medical Center Utrecht specializing in medicine, radiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1K
2	Health Sciences	14	15	828
3	Engineering	7	7	420
4	Social Sciences	2	2	90
5	Public Health	1	1	21

Peter P. van Rijk

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
U-SPECT-I: a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. Freek J. Beekman, Frans van der Have, Brendan Vastenhouw, PubMed	2005	299
F‐18‐fluoro‐deoxy‐glucose positron‐emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer Chris H.J. Terhaard, Vivian Bongers, Peter P. van Rijk, Head & Neck	2001	162
Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques J. Frank W. Nijsen, Bernard A. Zonnenberg, J. R. W. Woittiez, European Journal of Nuclear Medicine and Molecular Imaging Hepatic MalignanciesIntra-arterial Radionuclide TherapyNanomedicineOncologyHepatobiliary Tumor	1999	132
Preoperative Evaluation of Patients With Primary Head and Neck Cancer Using Dual-Head 18Fluorodeoxyglucose Positron Emission Tomography Marcel P. M. Stokkel, Frans-Willem ten Broek, Gerrit-Jan Hordijk, Annals of Surgery	2000	128
Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication–Naïve Patients with Generalized Social Anxiety Disorder Shown by<sup>123</sup>I-β-(4-Iodophenyl)-Tropane SPECT Nic J. van der Wee, J.F. Van Veen, Henk Stevens, Journal of Nuclear Medicine	2008	103
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. John M. H. de Klerk, Anouk van Dijk, Alfred D. van het Schip, PubMed Whole BloodPharmacotherapyOsteoporosisRadiation MedicineBrachytherapy	1992	103
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer Marcel P. M. Stokkel, Karel Moons, Frans-Willem ten Broek, Cancer	1999	98
Comparison of methods for thyroid volume estimation in patients with Graves' disease Johannes W. van Isselt, John M. H. de Klerk, Peter P. van Rijk, European Journal of Nuclear Medicine and Molecular Imaging Thyroid DiseaseThyroid DisordersBiostatisticsThyroid HormoneStatistics	2003	95
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. Shiuw H. Han, John M. H. de Klerk, Suzy Tan, PubMed	2002	90
Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose–volume response relationships Judith M. Roesink, Marinus A. Moerland, A. Hoekstra, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyDose–volume Response RelationshipsHead-and-neck CancerMedicine	2004	89

Page 1